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Case report Carcinoma ex pleomorphic adenoma of soft palate 
with cavernous sinus invasion
Hsuan-Ho Chen1, Li-Yu Lee2, Shy-Chyi Chin3, I-How Chen1, Chun-Ta Liao1 and Shiang-Fu Huang*1
Abstract
Background: Carcinoma ex pleomorphic adenoma (CXPA) is an aggressive salivary gland malignancy and rare in 
minor salivary gland. A soft palate CXPA initially presenting as direct cavernous sinus (CS) invasion is very rare.
Case Presentation: A 60-year-old male had a 3-month history of a small soft palatal mass with progressing left cheek 
numbness, proptosis, and disturbed vision. Biopsy of soft palatal tumor showed pleomorphic adenoma. Magnetic 
resonance imaging showed a tumor involving left maxilla, and extended from pterygopalatine fossa, inferior orbital 
fissure to CS. Excision of tumor revealed CXPA. Adjuvant concomitant chemo-radiation therapy (CCRT) was given. The 
tumor recurred 5 months later in left CS which was re-treated with CCRT. The disease status was stable at 2 years after 
the diagnosis of CXPA.
Conclusion: We present this case to emphasize that patients with symptoms such as facial numbness, proptosis and 
disturbed vision should be carefully investigated for lesions invading CS by perineural spread.
Background
Carcinoma ex-pleomorphic adenoma (CXPA) is a rare,
aggressive, poorly understood malignancy that usually
develops in a primary or recurrent pleomorphic adenoma
(PA) [1]. The pathogenesis has not been well understood.
CXPA accounts for 3.6% of all salivary neoplasms and for
11.7% of salivary malignancies [2]. Less than 7% of the
cases occur in the palatal minor salivary glands [3]. Mis-
diagnosis is not uncommon because the carcinoma may
represent various subtypes in the residual PA on micro-
scopic examination [1]. Imaging study of CXPA usually
presents as non-specific characteristics [4]. We describe a
60-year-old male diagnosed as a CXPA of the soft palate
with direct cavernous sinus (CS) invasion. The initial pre-
sentations of his disease were left cheek numbness, prop-
tosis and blurred vision which were rarely reported in the
literature [5].
Case presentation
A 60-year-old male visited our hospital for left cheek
numbness for 3 months. A painless soft palatal mass was
noticed and became more prominent recently (Figure 1).
Physical examinations of the head and neck revealed an
area of numbness in the distribution of 2nd division of
trigeminal nerve, proptosis, and disturbed visual acuity at
the level of counting fingers. He also had left esotropia
which was due to traumatic left abducens nerve palsy by
saw dust 10 months ago. Biopsy of the tumor revealed
PA.
Computed tomography of head and neck showed
asymmetry with some bulging contour at palatal region.
Magnetic resonance imaging (MRI) arranged revealed
irregular soft tissue mass involving left maxilla, and
extended from pterygopalatine fossa, inferior orbital fis-
sure to CS with bony destruction of the skull base (Figure
2). We performed total maxillectomy with free flap
reconstruction intending to radically excise the tumor. At
surgery, we explored the pterygopalatine fossa but com-
plete excision of tumor was infeasible at the skull base.
After excision of the tumor, immunohistochemical study
revealed actin (+), CD10(+), Calponin (+), and CK14(+).
Final pathologic report was CXPA of salivary duct carci-
noma subtype, with perineural, lymphatic and bony inva-
sion (Figure 3). Concurrent chemo-radiotherapy (CCRT)
was given after surgery due to positive resection margin
and advanced tumor stage. The tumor status was com-
pletely remitted without deterioration of visual acuity,
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proptosis and slightly improvement of left check numb-
ness (Figure 2).
Five months later, the patient complained of deterio-
rated visual acuity to the level of light sensation. The
functions of CN III and V2 were similar to that after 1st
CCRT. Follow-up MRI revealed the tumor recurred at left
CS. CCRT for the recurrence was implemented and the
disease has been in a stable condition. However, the
vision in his left eye was completely loss after the 2nd
CCRT.
Discussion
According to the World Health Organization histological
classification published in 2005, malignant changes in the
PA include three different types: CXPA, carcinosarcoma,
and metastasizing PA [3,4]. CXPA is the most common
malignant change and accounts for 11.7% of salivary
malignancies [2-4]. Most of the malignant changes occur
in the parotid gland and are extremely rare in minor sali-
vary gland [6]. There are only less than 7% of CXPA
found in the minor salivary glands [3]. The clinical pre-
sentation of CXPA may be similar to that of PAs and the
most common symptom was an asymptomatic mass and
sometimes there is a longstanding history of PA [1,7].
About 30% of patients present symptoms and signs
including pain, facial nerve palsy, enlarged lymph nodes,
skin ulceration and dysphasia [1,2]. CXPA usually occurs
in the 6th~8th decades of life [7]. The time from onset of
symptoms until diagnosis varied from 1 month to 52
years [2].
The imaging findings of CXPA are usually nonspecific
and difficultly identified from those of other benign and
malignant salivary gland tumors [4]. PA shows a variety of
signal intensities due to the cytomorphologic and archi-
Figure 2 T1-weighted magnetic resonance imaging scans (A) Axial section shows irregular soft tissue mass in left cavernous sinus (arrows) before 
treatment, (B) Coronal section shows swelling of left parapharynx and masticator space and tumor invading into left cavernous sinus (arrows) before 
treatment, (C) Axial section shows remission of tumor 3 months after CCRT, (D) Coronal section shows remission of tumor 3 months after CCRT.
Figure 1 A tumor measuring 1.2 × 1.0 cm located in left soft pal-
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tectural variabilities and is hard to be differentiated from
low-grade malignant tumors in the absence of an irregu-
lar margin or infiltration into the surrounding tissue [4].
The diagnosis of CXPA with multiple invasions was even-
tually found by the pathological examinations. The local
invasion from left maxilla to the CS was also demon-
strated. Through the literature, abducens nerve palsy
caused by the metastatic tumor in the CS had been
reported [3,7,8] but there is no CXPA with CS invasion
documented before. The tumor in the soft palate is read-
ily to spread by way of greater palatine nerve (within the
pharyngomaxillary fissure) toward the pterygopalatine
fossa (PPF). Once the tumor lodges in the PPF, there are 4
possible pathways via which the tumor can choose to
"travel": (1) anteriosuperiorly to the inferior orbital fissure
to extraconal space; (2) posterosuperiorly to the foramen
rotundum (V2) to the CS; (3) laterally to the masticator
space, then the trigeminal nerve gets invaded and
exploited as a route to the foramen ovale, dural layer and
CS; (4) medially via the sphenopalatine foramen to the
nasal cavity. Once the CS is invaded, the cranial nerves
that pass through the leaves of the CS or within the sinus
itself are affected, including cranial nerves III, IV, and VI
as well as the V1 and V2 branches of the trigeminal nerve.
Patients with CS invasion can present with headache,
chemosis, proptosis, exophthalmos, and/or disturbed
vision. The tumor in our patient was small in soft palate,
but evident local invasion and perineural spread into the
CS was seen on MRI. The perineural tumor spread may
be asymptomatic; therefore, imaging studies play a criti-
cal role in the evaluation. Imaging findings of perineural
spread of tumor include thickening and enhancement in
the involved nerve, a widened foramen at the skull base,
and obliteration of fat around the nerve as it exits the
skull base. A combination of T1-weighted images, with
and without contrast and fat saturation, best displays
perineural tumor spread [9-11]. In our patient, the initial
sign of CS invasion was cheek numbness. It is due to the
Figure 3 Microscopic findings. (A) Pleomorphic adenoma in a chondromyxoid, fibrotic and sclerotic stroma with the malignant areas of carcinoma 
component consisting epithelial clusters with necrosis. (H&E, 40×), (B) Carcinoma component is composed of cells with pleomorphic nucleus, mitotic 
activity and comedo-like necrosis. (H&E, 100×), (C) The carcinoma ex pleomorphic adenoma consisting benign pleomorphic adenoma and poorly dif-
ferentiated carcinoma with the ulcerative epithelial surface. (H&E, 40×), (D) Tumor cells presented the perineural invasion (H&E, 400×).Chen et al. World Journal of Surgical Oncology 2010, 8:24
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large sizes of maxillary and mandibular divisions of the
trigeminal nerve as they pass through the pterygopalatine
fossa and are vulnerable to invasion [9-12].
There are controversies on the treatment of CXPA in
salivary gland. The incidence of positive margins,
perineural invasion, facial nerve involvement, and lymph
node metastasis in CXPA is higher than other malignan-
cies of the parotid gland. Post-operative adjuvant radia-
tion could effectively eradicate residual deposits of
microscopic disease [13]. CXPA also shows the charac-
teristics of frequent recurrence and metastasis [7]. Meta-
static lesions most frequently occur in regional lymph
nodes, and some of them are seen in lung and bone [14].
Currently, surgery and post-operative adjuvant radiation
therapy is accepted to improve local tumor control and a
better tumor control is further associated with increased
survival [8,13]. The 5-year survival rate of CXPA ranges
from approximately 25% to 65% [14]. In our patient, com-
plete excision of the tumor in CS was infeasible and it was
further controlled by post-operative CCRT. Although the
tumor recurred near CS later, re-irradiation is applicable
and could achieve tolerable local tumor control.
Conclusion
CXPA in the minor salivary gland with direct CS invasion
was very rarely met. Our case is exceptional because the
size of tumor in soft palate was small and not growing
into the oral cavity. Instead, it spreads extensively
through PPF and directly into the CS. It illustrates an
atypical clinical presentation of the CXPA and the diffi-
culty in its management.
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